The effect of formalin in the treatment of wart
Phase 3
- Conditions
- Wart.Viral warts
- Registration Number
- IRCT20200530047603N1
- Lead Sponsor
- Ahvaz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Diagnosis of plantar wart and common wart in the hands and feet
Exclusion Criteria
Patients with a history of formaldehyde allergy
Immunodeficiency
Severe dermatitis
Diabetes
Pregnancy or lactation
History of respiratory illnesses such as asthma
Any treatment for wart in the last two weeks
Taking immunosuppressive drugs
Any severe systemic disease
Patients with peripheral vascular disorder
Patients with peripheral neuropathy
Patients who also have other skin conditions such as lichen planus, psoriasis or eczema in the site of wart lesions
Inability to cooperate in using topical drugs due to young age or sensory impairment
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wart count change. Timepoint: Before intervention and then every 4 weeks during intervention and three months after the end of the treatment. Method of measurement: By counting wart number.
- Secondary Outcome Measures
Name Time Method Dryness. Timepoint: Every 4 weeks during intervention. Method of measurement: Questionnaire.;Erythema. Timepoint: Every 4 weeks during intervention. Method of measurement: Questionnaire.;Fissuring. Timepoint: Every 4 weeks during intervention. Method of measurement: Questionnaire.